Header Logo

Connection

Robin Jones to SMARCB1 Protein

Back to Details
This is a "connection" page, showing publications Robin Jones has written about SMARCB1 Protein.
Robin Jones
Connection Strength
0.185
SMARCB1 Protein
  1. Tazemetostat in advanced epithelioid sarcoma with loss of INI1/SMARCB1: an international, open-label, phase 2 basket study. Lancet Oncol. 2020 11; 21(11):1423-1432.
    View in: PubMed
    Score: 0.185
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.